K212132: FreeStyle Libre 3 Continuous Glucose Monitoring System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K212132 (FreeStyle Libre 3 Continuous Glucose Monitoring System, cleared 2022-05-26 for Abbott Diabetes Care, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K212132 |
| Cleared Device Trade / Generic Name | FreeStyle Libre 3 Continuous Glucose Monitoring System |
| FDA Applicant on Filing | Abbott Diabetes Care, Inc. |
| FDA 3-Letter Product Classification | Product Code QLG |
| FDA Substantial Equivalence Decision Date | 2022-05-26 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Abbott Laboratories across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Abbott Diabetes Care, Inc., compare peer devices under FDA Product Code QLG, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.